Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.fatetherapeutics.com
Fate Therapeutics, Inc. News Releases
Get the latest updates from Fate Therapeutics, Inc. News Releases directly as they happen.
Follow now 67 followers
Latest posts
Last updated 7 days ago
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs
7 days ago
FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile...
Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
20 days ago
SAN DIEGO , Nov. 25, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
about 1 month ago
Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
about 1 month ago
SAN DIEGO , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
about 2 months ago
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory...
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
2 months ago
SAN DIEGO , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2 months ago
SAN DIEGO , Oct. 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
3 months ago
SAN DIEGO , Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics to Present at Upcoming Investor Conferences
4 months ago
SAN DIEGO , Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
4 months ago
First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
4 months ago
SAN DIEGO , Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
5 months ago
SAN DIEGO , July 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc...